Victoria Newbould Anne Gyllensvärd Christina Winter* Dwana Pritchett Health Canada, Canada Lynn Macdonald Yutaka Nagao Kazuyuki Sekiguchi JMO Mitsuru Takano Tomoko Narita Yo Tanaka JPMA Hitomi Takeshita Miyako Shionoiri Judy Harrison MSSO David Richardson Miki Ohta Takayuki Okubo MHLW/PMDA, Japan Akina Takami Yuka Tamura Eno PhRMA Milbhor D’Silva Brajovic# FDA, US Christopher Breder Won Im Do MFDS, Republic of Korea Yong Seok Ko WHO Daisuke Tanaka * Current Rapporteur, # Regulatory Former members of the ICH Points to Consider Working Group Affiliation Member
Victoria Newbould Anne Gyllensvärd Christina Winter* Health Canada, Canada Dwana Pritchett Lynn Macdonald JMO Yutaka Nagao Kazuyuki Sekiguchi Mitsuru Takano Tomoko Narita JPMA Yo Tanaka Hitomi Takeshita Miyako Shionoiri MSSO Judy Harrison David Richardson MHLW/PMDA, Japan Miki Ohta Takayuki Okubo Akina Takami Yuka Tamura Eno PhRMA Milbhor D’Silva FDA, US Brajovic# Christopher Breder MFDS, Republic of Korea Won Im Do Yong Seok Ko WHO Daisuke Tanaka * Current Rapporteur, # Regulatory Former members of the ICH Points to Consider Working Group Affiliation Member
000157_datretptc_r3_15_mar2018.docx